CanFaster- The translational cancer faster forward doctoral programme
The CanFaster program is supported by the European Union’s Marie Skłodowska-Curie programme, which is part of the Horizon 2020 framework and based on the "Mobility across boarders" philosophy.
The CanFaster program aims to attract excellent international PhD candidates with an interest in applied medical research in oncology and entrepreneurship to Lund University, CREATE health and Medicon Village.The program build on collaboration between industry, healthcare and academia to strengthen and accelerate innovations and clinical implementation in oncology. The 16 PhD students will gain an understanding of unmet needs in the clinic and learn the mind-set of entrepreneurs in an upcoming PhD program within cancer.
The program will give the excellent PhD candidates the appropriate training, experience, and guidance to combine research with efforts to create innovations from it. A rich and comprehensive training program is offered in combination with secondments in the non-academic sector, such as clinic or industry. The program will result in a new type of entrepreneurship-PhDs with knowledge in innovations processes as well as start-up processes.
The young researchers - to be trained in an academic as well as non-academic setting - will become true innovators, enforced with a broad set of scientific, transferable, and business skills.
There has been two open calla, selecting 16 excellent PhD candidates, scheduled as follows:
First call is September 2017 and the deadline for the submission of applications was 17th of November 2017.
Second call in April, and the deadline for the submission of applications was 6th of May 2018.